The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions - Chiappetta, G; Toti, P; Cetta, F (J Clin Endocrinol Metab, 2002)
et al.